The study showed as its main finding that the use of HDx therapy enabled by the Theranova dialyzer was not associated with any significant changes in serum albumin concentrations over time, and there was no significant difference as compared to the HF‐HD cohort. This evidence concerns the gene ALB and hydrops fetalis.